Study: Low-dose PET/CT best for lymphoma staging

12/8/2008 | Diagnostic Imaging

A Spanish study found that low-dose PET/CT achieved the best sensitivity and specificity for the initial staging of biopsy-proven non-Hodgkin's lymphoma and Hodgkin's lymphoma compared with contrast-enhanced CT. This imaging method could reduce the radiation dose and eliminate the need for intravenous iodinated contrast materials, the lead researcher said.

View Full Article in:

Diagnostic Imaging

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ